Study Results & Research Projects

Summaries & Associations of Study Results

TR-269 1,3-Dichloropropene (Telone II)

Print this page Easy Link

http://ntp.niehs.nih.gov/go/10779

Target Organs and Levels of Evidence
NTP Technical Report Number 269

Produced from Chemtrack Database 09/19/01

CHEMICAL/ CAS NUMBER PEER REVIEW DATE PRIMARY USES ROUTE/EXPOSURE LEVELS STUDY LABORATORY
1,3-DICHLOROPROPENE (TELONE II)
542-75-6
07/27/84 SOIL FUMIGANT, NEMATOCIDE (MERCK 1989) Gavage R: 0,25,50, M: 0,50,100 MG/KG/50 PER GROUP Frederick Cancer Research Facility
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM):
MR: CLEAR EVIDENCE FORESTOMACH: SQUAMOUS CELL PAPILLOMA 1/52 1/52 9/52; SQUAMOUS CELL CARCINOMA 0/52 0/52 4/52
LIVER: NEOPLASTIC NODULE 1/52 6/52 7/52
NON-NEOPLASTIC LESIONS: FORESTOMACH: HYPERPLASIA, EPITHELIAL; HYPERPLASIA, BASAL CELL
FR: SOME EVIDENCE FORESTOMACH: SQUAMOUS CELL PAPILLOMA 0/52 2/52 3/52
NON-NEOPLASTIC LESIONS: FORESTOMACH: HYPERPLASIA, EPITHELIAL; HYPERPLASIA, BASAL CELL
MM: INADEQUATE STUDY
NON-NEOPLASTIC LESIONS: FORESTOMACH: HYPERPLASIA, EPITHELIAL
URINARY BLADDER: HYPERPLASIA, EPITHELIAL
FM: CLEAR EVIDENCE URINARY BLADDER: TRANSITIONAL CELL CARCINOMA 0/50 8/50 21/48
LUNG: ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 3/50 8/50
FORESTOMACH: SQUAMOUS CELL PAPILLOMA 0/50 1/50 2/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 2/50 COMBINED 0/50 1/50 4/50
NON-NEOPLASTIC LESIONS: FORESTOMACH: HYPERPLASIA, EPITHELIAL
URINARY BLADDER: HYPERPLASIA, EPITHELIAL